{
  "trial_id": "NCT03796598",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Cirrhosis diagnosed by either of the following in a patient with chronic liver disease",
      "label": "met",
      "evidence": "Liver Biopsy"
    },
    {
      "criterion": "Radiologic evidence of varices, cirrhosis or portal hypertension",
      "label": "met",
      "evidence": "Grade II Esophageal varices"
    },
    {
      "criterion": "On treatment for hepatic encephalopathy (patient can be on lactulose and rifaximin)",
      "label": "met",
      "evidence": "Patient was given a presumptive diagnosis of hepatic encephalopathy and started on lactulose."
    },
    {
      "criterion": "Able to give written, informed consent (demonstrated by mini-mental status exam>25 at the time of consenting)",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "MELD score >22",
      "label": "not_met",
      "evidence": "Liver function tests showed a striking increase in his total and direct bilirubin since last visit."
    },
    {
      "criterion": "WBC count <1000 cells/mm3",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "Patient has cirrhosis, varices, and is on treatment for hepatic encephalopathy. However, MELD score >22 may be a concern.",
  "_meta": {
    "topic_id": "7",
    "trial_id": "NCT03796598",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}